Leishmaniasis affects more than 12 million humans globally and a further 1 billion people are at risk in leishmaniasis endemic areas. The lack of a vaccine for leishmaniasis coupled …
Background Leishmaniasis is a neglected tropical disease caused by a group of protozoan of the genus Leishmani a and transmitted to humans majorly through the bite of the female …
Leishmaniasis affects more than twelve million people globally and a further one billion people are at risk in leishmaniasis endemic areas. The lack of a vaccine for leishmaniasis …
The enzyme pyridoxal kinase (PdxK) catalyzes the conversion of pyridoxal to pyridoxal-5′- phosphate (PLP) using ATP as the co-factor. The product pyridoxal-5′-phosphate plays a …
Abstract d-ribose is a critical sugar substrate involved in the biosynthesis of nucleotides, amino acids, and cofactors, with its phosphorylation to ribose-5-phosphate by ribokinase …
N Razzaghi-Asl, N Hashemi - Journal of Molecular Graphics and Modelling, 2022 - Elsevier
Leishmaniasis is a parasitic disease with frequent annual incidence. An important issue in chemotherapy is the emergence of resistance, toxicity and lack of cost-effectiveness within …
M Saini, S Are, IA Qureshi - Current Protein and Peptide …, 2022 - ingentaconnect.com
Human parasites cause several diseased conditions with high morbidity and mortality in a large section of the population residing in various geographical areas. Nearly three billion …
Over twelve million individuals worldwide suffer from leishmaniasis, and an additional billion people are at risk in places where the disease is prevalent. This work was motivated by the …
Leishmaniasis affects more than twelve million people globally and a further one billion people are at risk in leishmaniasis endemic areas. The lack of a vaccine for leishmaniasis …